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Abstract
Immigration is a growing flow in Italy. Also specific health needs could be imported. 
We focused on cancer. A systematic search for literature in PubMed was performed on 
10th March 2016, limited to articles published between 1st March 1996 and 1st March 
2016. Papers were reviewed focusing on: specific risks, prevention and care. Cancer in-
cidence is generally lower for immigrants than for natives, also for the health immigrant 
effect. However, cancers with an infective etiology may have, among some groups of 
immigrants, a great relevance. Primary or secondary cancer prevention could be greatly 
improved among immigrants. Moreover, another specific aspect of immigration is at 
seeking cancer care for children. Specific preventive strategies should be customized 
for immigrants to get higher compliance, e.g. for those at high risk for cervical cancers. 
Moreover, the capability of the Italian health system to cope more comprehensively with 
sick immigrated children and their families should be improved.
INTRODUCTION
Italy is a country with a long past of emigration but in 
quite recent years has become one of the most carved 
and crowded doors for those immigrants who want to 
enter Europe.
Immigration has among the political, humanitarian, 
social and cultural perspectives also health implications. 
Migrants may share some characteristics which affect 
their health status, for example the “natural” selection 
of those people strong enough to get through the or-
deals of migrating. Moreover, any different migrants’ 
group, may have a different risk pattern related to spe-
cific cultural life styles which steer risky exposures (e.g. 
diet, fecundity, etc.) [1].
Therefore, immigrated populations may have specific 
characteristics, needs, susceptibilities, risks, which have 
to be known, documented, and considered, to offer 
them, and make easily usable, the same services avail-
able for the Italian natives together with customized as-
sistance, if necessary.
The aim of this study was to review the literature for 
papers published in the last twenty years focusing on can-
cer in immigrants in Italy, to underline those topics which 
need to be addressed by specific health interventions.
METHODS
We searched in PubMed publications, published be-
tween 1st March 1996 and 1st March 2016, matching 
the following search terms: ((immigrant* and (Italy or 
Italian) and cancer) or (migrant* and cancer and (Italy or 
Italian)) or (immigrant* and (Italy or Italian) and tumor) 
or (migrant* and tumor and (Italy or Italian)) or (immi-
grant* and (Italy or Italian) and tumour) or (migrant* 
and tumour and (Italy or Italian)) or (immigrant* and 
(Italy or Italian) and neoplasia) or (migrant* and neo-
plasia and (Italy or Italian)) or (immigrant* and (Italy or 
Italian) and neoplasm*) or (migrant* and neoplasm* and 
(Italy or Italian)) or (immigrant* and (Italy or Italian) and 
in-situ) or (migrant* and in-situ and (Italy or Italian) ))). 
The search was performed on 10th March 2016. 
The search identified 85 papers. We went through the 
titles and the abstracts to identify pertinent articles: 31 
were about non pertinent topics (e.g. infectious diseas-
es among immigrants), 16 were not related to migration 
in Italy (e.g. migration of Italians within Italy, or of Ital-
ians abroad), 1 was a case-report (on a migrant lesion), 
1 was written in Hungarian. After the exclusions, 36 
papers were left. For one of them neither the abstract 
nor the full text was available.
Full texts of the remaining 35 studies were evaluated 
and three main general topics were presented: cancer 
risk factors, cancer prevention and cancer care.
RESULTS
Migration in Italy
In 2015 in Italy, according to the Italian National 
Address for correspondence: Alessandra Ravaioli, Registro Tumori della Romagna, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori 
(IRST) IRCCS, Via Piero Maroncelli 40, 47014 Meldola (FC), Italy. E-mail: alessandra.ravaioli@irst.emr.it.
ImmIgrants and cancer In Italy
O
r
ig
in
a
l
 a
r
t
ic
l
e
s
 a
n
d
 r
e
v
ie
w
s
239
Institute of Statistics (Istat; www.demo.istat.it), there 
were 5 014 437 resident citizens with a foreign citizen-
ship (8.2% of the overall resident population), 2 372 796 
of them were men (8.0% of the men resident) and 
2 641 614 (8.4%) women. The foreign population has 
grown at a staggering pace, its number has increased of 
about 1 million since 2012 (4 052 081 in 2012, 6.8% of 
the overall residents).
In Table 1 the ten most frequent countries for citi-
zenship of immigrated in Italy are shown. About 1/4 
of all the foreign citizens come from Romania (23.6%), 
and other four European countries rank in the first ten 
places (Albania, Ukraine, Republic of Moldavia, and 
Poland); then there are three Asian countries: Republic 
of China, Philippines and India, and two countries from 
North Africa: Morocco and Tunisia.
Migration in Italy and cancer occurrence
We found out only a few papers which coped with the 
occurrence of cancer in migrants in Italy, which offer a 
scattered coverage of epidemiological indexes in local 
settings. Before describing such studies we have to un-
derline that the migrant populations are usually young. 
In Figure 1 the Italian resident population is presented 
by citizenship (Italian and foreign) with their percent-
age distributions by 10-year age groups (Istat; www.
demo.istat.it). It is evident that the foreign population 
is strikingly younger than the Italian one, not only for 
the greater amount of children but also for all the first 
five decades. Afterwards, the relevance of Italians in-
creases and among the elderly there are just a few for-
eigners. Out of age, in comparing native and migrant 
populations, we have to take into account the “healthy 
migrant effect” which means that migration itself selects 
healthy people. This can contribute to the lower global 
cancer incidence evidenced for immigrants, especially 
coming from developing countries with high migration 
rate (Paesi a Forte Pressione Migratoria, PFPM), than 
for Italians [2]. 
This effect may also influence the lower global and 
cancer specific mortality evidenced in migrants in both 
sexes in comparison with Italian natives [3]. Some 
clues for the healthy migrant effect come also from 
the causes of hospitalization [4]; in fact, among acute 
care the most frequent causes for immigrants were 
traumatic accidents, which represented almost ¼ of all 
the hospitalizations, while they were 8.9% for Italians 
[5]. Moreover, the healthy migrant effect, but also the 
shorter length of residence, may contribute to explain 
the lower proportion of cancers diagnosed among im-
migrant (0.9%) than among Italian workers (2.2%) in 
the Lazio region (central Italy) in 2000-9 [6]. 
As regards skin cancers, 1474 patients coming from 
outside the European Community were compared with 
2100 Italians, all referred at the Institute of Dermatol-
ogy of the University of Rome during 1989-1994. These 
groups were of the same age (20-39 years) and sex. Skin 
cancer were uncommon in both groups; benign lesions 
(such as fibromas, nevi, cysts, etc.) were 15.8% among 
the Italians and less that the half, 6.7%, among the im-
migrants [6].
Migration in Italy and cancer risk factors
Cancer risk factors may be different in distinct popu-
lations, and studies carried out in migrant populations 
have greatly contributed to split the role of genetic and 
environmental factors in cancer development. 
Although the term of migrant is used for very differ-
ent people, at least for some of them, or more realisti-
cally for many, their condition corresponds to a low lev-
el of socioeconomic status. This is a well-documented 
risk factor for many cancers: lung, stomach, oral cavity, 
esophagus, cervix uteri. For some of those cancers the 
relationship is related to specific risk factors, as we later 
will show. The status of immigrant has been evaluated 
among other socioeconomic conditions in relationship 
to cancer but also to many other health and social states 
by Caiazzo et al. [7]. 
Xeroderma pigmentosus (XP) is an example of a 
genetic autosomal recessive disease caused by defects 
in the repair damaged DNA. An international study 
tested the frequency of XP and other similar diseases 
in 5 European countries, considering that its incidence 
is estimated to be 1 case every million in Europe, but 
more frequent in other countries (e.g. North Africa). 
In 1988-2004 in Italy, the incidence of XP was mainly 
evidenced in autochthonic patients, on the contrary in 
German, France, Netherlands and United Kingdom 
more than half of the patients belonged to immigrant 
populations; presumably because at that times the im-
migrants were less frequent in Italy than in the other 
countries [8]. 
Moreover, some cancer risk factors are related to a 
Western-type life. This, for example, could greatly con-
tribute to explain the lower risk for female breast cancer 
in immigrants than in Italians (e.g. age at menarche, 
number of children, breast feeding, etc.) [2] and conse-
quently, together with the younger age, could contrib-
ute to explain the lower rate of mastectomy identified 
in Italian hospital discharge codes, during 2006-8, be-
tween immigrants in comparison with Italians [9]. 
Among other well-known risk factors we underline 
Table 1
The ten most frequent countries of citizenship for foreign citi-
zens resident in Italy, 2015 
Country Residents Foreign 
citizens (%)
Women 
(%)
Romania 1 181 839 23.6 54.5
Albania 490 483 9.8 48.1
Morocco 449 058 9.0 45.9
Republic of China 265 820 5.3 49.0
Ukraine 226 060 4.5 79.0
Philippines 168 238 3.4 56.4
Republic of 
Moldova
147 388 2.9 66.1
India 147 815 2.9 39.9
Poland 98 694 2.0 73.3
Tunisia 96 012 1.9 38.1
From: www.istat.it
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that the prevalence of overweight and obesity, although 
not negligible in adults resident in North Africa, es-
pecially among women, increases after emigration to 
European countries [10]. The relationship between vi-
tamin D and cancer is still under debate; however, it 
is worthwhile mentioning the deficiency of vitamin D 
identified in Piedmont among immigrants new-borns 
and in their mothers [11].
Among cancer risk factors those which have been 
more deeply evaluated in immigrant populations to 
Italy are infections. Infectious diseases were overall 
the most frequent cause of day care hospitalization for 
men illegal immigrants (42.7%), and also for legal ones 
they were more than for Italians (9.4% vs 3.0%). Among 
women the differences were still statistically significant 
but less striking (legal immigrants 3.4%, illegal 7.3, Ital-
ians 1.6, p < 0.0001) [4].
As regards HIV type-1 infection, the prevalence of 
genetic strains seems to have been strongly modified 
in the last 10-15 years, due to the flows of HIV non-
B variants which are more common in the population 
of North Africa [12]. This situation is common to sev-
eral European countries, including Italy, as an effect of 
migration of populations from Western and Northern 
Africa, where non-B sub-types and Circulating Recom-
binant Forms are prevalent. The changes in the genetic 
pattern of HIV have not just an epidemiological inter-
est but also an impact on drug resistance and vaccine 
development [13].
The prevalence of hepatitis B virus (HBV) infections 
is strongly heterogeneous across countries and it might 
be particularly high in some of those countries from 
which the immigration to Italy is particularly common, 
e.g. Republic of China (HBV prevalence 10%), Philip-
pines (8%), Tunisia (7%) [14].
Migration is sometimes associated with the fear 
for the introduction of new infectious in our country. 
A study, carried out in 2003-4, focused on Human T-
lymphtropic virus type I (HTLV-1), an infection etio-
logically linked with adult T-cell leukemia. HTLV-1 is 
sporadic in Italy and it is restricted to immigrants ar-
riving from Japan, the Caribbean, South America, Sub-
Saharan Africa, Melanesia and the Middle East. The 
study enrolled 3408 HIV-1/2 negative immigrants from 
Africa who referred to the Sexually Transmitted Disease 
clinic and/or Oncologic department of the University 
of Bologna, and 534 blood donors. The study revealed 
2 HTLV-1 infections in immigrates from Africa, corre-
sponding to a very low prevalence, 0.058% [15].
Human Papilloma Virus (HPV) is the most docu-
mented infective exposure in immigrant female popu-
lations in Italy. In a sample of 45 women, mainly from 
Nigeria (84.4%) and with a high proportion with history 
of prostitution (44.4%), 42.2% of them were HPV posi-
tive. This proportion was higher, 57.1%, among those 
who were also HIV positive (31.1% HIV+), in compari-
son with those HIV negative, 35.5% [16]. In another 
group of 115 women immigrated in Sicily (south of Ita-
ly), enrolled among those who had attended in 2007-8 
the main hospital of the city of Palermo for performing 
a gynecological examination, Pap smear and HPV test-
ing, almost half of them (47.8%) were HPV+. The pro-
portion of women with HVP+ was 45.0% among those 
from sub-Saharan Africa (27/60) and 51.0% among 
those from Eastern Europe (28/55). The most frequent 
HPV oncogenic types were 16 (7.8%), 18 and 51 (6%), 
52 (5.2%), 31, 53, and 68 (4.3%) [17].
The pooled analysis of three large studies on HPV 
prevalence in cervical cancer in Italy included 526 cases 
from women born in Italy and 48 cases from women 
born abroad. In this study the distribution of HPV gen-
otypes did not differ significantly between Italian and 
born abroad women, with the exception of an excess for 
HPV oncogenic types 33 in immigrants with borderline 
statistical significance (p = 0.076) [18]. The prevalence 
of HPV infection was evaluated in 233 migrants and 
compared to 98 native Italian women. The prevalence 
was 37.8% among the native Italians, 57.1% (32/56) 
among migrants from Africa, 59.7% (92/154) for those 
coming from Southern and Eastern Europa, 62.5% 
(5/8) for migrants from Southern and Central America 
and 73.3% for migrants from Southern Asia. 73.4% of 
all infections were due to carcinogenic HPV genotypes 
[19]. A higher proportion of HPV+ among immigrat-
ed than Italian native women has been observed also 
in Northern Italy, especially in women migrated from 
countries with high prevalence of HPV [20].
One thousand recently migrated women (26-65 
years) are one of the high risk groups involved in a co-
hort study planned in Lombardy region (northern Italy) 
for the evaluation and the monitoring of HPV infec-
tions and related cervical diseases in high risk women; 
this study is planned to provide results in 5-years [21].
Migration in Italy and cancer preventive activity
In Italy there are population-based public screening 
programs for female breast, colorectal and cervical can-
cers. The programs are based on active invitation ad-
dressed to all the target population (according to sex 
and age span), they include free screening testing, sec-
ond level exams and treatment, and a comprehensive 
quality evaluation and monitoring of all the steps.
For the three mentioned cancers the risk for people 
immigrated from developed countries is similar to 
that of Italian natives. On the other hand, migrants 
from PFPM have generally a lower risk for breast and 
colorectal cancers. However, cervical cancer is much 
more frequent in PFPM than in Italian native citizens 
[2]. 
Moreover, in Italy since 2007 a HPV vaccination 
campaign addressed to all the girls 11-year old has been 
implemented. A survey carried out in Lombardy region 
among mothers showed that 55.3% of their daughters 
got the first dose of vaccine, 54% the second and 49.4% 
the third and last. Mothers coming from countries oth-
er than Italy were less informed about the pathogenesis 
of cervical cancer and about the efficacy of the vaccina-
tion, in comparison with Italian ones [22].
A recent survey was carried out on the Italian behav-
ioral risk factors surveillance system (Progressi delle 
Aziende Sanitarie per la Salute in Italia, PASSI) based 
on information collected via telephone calls (during 
2010-2013) on a random sample of the resident pop-
ulation in local health authorities. Among the other 
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questions, some were addressed to screening activity 
either within the public programs or as spontaneous 
tests performed privately [23]. As regards cervical can-
cer, 77% of the 25-64 year-old Italian women or women 
from industrialized countries similar to Italy have had a 
Pap smear or an HPV test in the previous three years, 
52% of them within a screening program and 48% out-
side. A lower proportion (71%) of the immigrants from 
PFPM had performed a Pap smear or an HPV test, but 
most of them (66%) within the screening program. As 
regards mammography, the proportion of participants 
in screening program among 50-69 year-old Italian or 
foreign women was almost the same (51% vs 49%), 
while the proportion of those who had a spontaneous 
screening were rather different (38% vs 12%). Finally, 
the PASSI study confirmed also for colorectal cancer 
screening (addressed to 50-69 year-old people) a simi-
lar participation to the screening program for Italian 
and Italy-like countries and for immigrants from PFPM 
(31% and 29%) and a lower participation to spontane-
ous screening for the latter (7% vs 4%) [23].
In 2013, the National Centre for Screening Moni-
toring (Osservatorio Nazionale Screening, ONS) per-
formed a survey on colorectal screening program, to 
which participated 85 of the 120 programs active. The 
aim was to compare natives in Italy with immigrants 
from low- or middle-income countries. Participation 
was lower for immigrants (34.3%) than for Italians 
(51.3%). Participation was higher among women (Ital-
ians and immigrants) than men, and among Italian 
born it increased with age while it decreased among 
migrants. The positivity to test standardized rate was 
higher for immigrants (Italians 4.4% vs Immigrants 
4.8%, p < 0.05), while the participation rate to colo-
noscopy was almost the same (81.8% vs 80.5%), as the 
detection rate for carcinoma and advanced adenoma at 
first (1.62‰ vs 1.34‰) and at repeated ones (9.25‰ vs 
8.41‰) [24]. On the contrary, in the Umbria region, 
where 12.2% of the resident female population come 
from PFPM, to be from PFPM in the cervical screen-
ing program was associated with a greater probability 
(in comparison with women from not PFPM, 97% from 
Italy and 3% from developed countries) to be referred 
for colposcopy (Odds Ratio (OR) adjusted for age, and 
for previous participation to cytology screening, 1.6, p 
= 0.002), to have a diagnosis of a cervical tumor (OR 
4.2, p = 0.009), to have a diagnosis of squamous cell 
carcinoma (OR = 2.7, p = 0.1) and of a cervical adeno-
carcinoma (OR 11.6, p = 0.01) [25].
As regards cervical cancer screening, in Reggio Emil-
ia (Northern Italy), the participation was higher for Ital-
ians (67%) in comparison with foreign women (54%), 
especially coming from countries with a prevalence of 
HPV above 12.6% (high human papillomavirus preva-
lence countries (HHPVC): Africa, except north Africa, 
Central and South America, and Eastern Europe) [20]. 
On the contrary the risk of a cervical cancer diagnosis 
was higher for foreign women both for invasive lesions 
(Standardized Incidence Ratios (SIR) 2.4, 95% Confi-
dence Interval (CI)1.4-3.8) and for CIN3 (SIR = 1.2, 
95% CI 1.9-1.4) [20]. All the tumor risk for foreign 
women was carried by those from HHPVC (SIR for 
invasive tumors 4.1, 95% CI 2.2-6 and for CIN3 SIR 
= 2.0, 95% CI 1.7-2.5). The ratio between pre-invasive 
(CIN3) and invasive cervical lesion was lower in foreign 
women (2.6 for those from HHPVC, and 3.6 for the 
others) in comparison with Italians (7.4). Pre-invasive 
lesions are asymptomatic and they can be detected only 
by Pap test; therefore, the low ratio is an index for low 
screening participation [20].
The participation of foreign women to cervical cancer 
screening has been also evaluated by Visioli et al. [26] 
who reviewed the cohort of invited women during three 
following screening rounds in Florence (Central Italy) 
during 2002-2008. The attendance at the first round was 
33.9% for Italians, 29.6% for women from developed 
countries and 21.6% for those from PFPM. Although in 
all the three groups the participation had increased in 
the second and third round, the gap among groups did 
not change (in the third round Italians 57.4%, devel-
oped countries 50.2% and PFPM 45.4%). The risk ra-
tio of participating to the cervical cancer screening was 
lower for foreign women (developed countries 0.88 at 
1st round and 0.89 at 2nd or 3rd, and for PFPM women 
0.65 at 1st and 0.80 at 2nd or 3rd round) than for Ital-
ian (reference = 1). The odds ratio of developing a high 
grade squamous intraepithelial cytology or worse was 
twice higher for immigrants from PFPM (OR = 2.09) or 
from developed countries (2.22) that for Italians [26].
The participation of immigrant women to cervi-
cal screening has been widely investigated in a survey 
recently carried out by the Italian Group for Cervical 
Cancer Screening (GISCi) in a study to which partici-
pated 48 out of the 120 active programs. In 2009-2011, 
among women aged 25-64 years, the participation 
was 45.4% for Italians and 39.9% for foreigners. The 
age-adjusted relative risk (RR) of Atypical Squamous 
Cells of Undetermined Significance + (ASC-US+) was 
higher for immigrated (RR = 1.25, 95% CI 1.24-1.27), 
including High-grade Squamous Intraepithelial Lesion 
(HSIL) (RR = 1.78, 95% CI 1.71-1.86) and cancer (RR 
= 3.33, 95% CI 2.57-4.31). The compliance to colpos-
copy was almost the same (90.3% vs 89.7%). It must 
be mentioned that the proportion of undelivered letters 
was 0.9 for those addressed to Italian women and 4.3% 
to immigrants [27].
Almost the same results were confirmed in a survey 
including those Italian pilot screening programs HPV 
DNA-based. Resident women born outside Italy had a 
RR of 0.84 (95% CI 0.82-0.85) to participate; participa-
tion: 52.2% for those born in Italy vs 43.6 born outside. 
To this difference could have played also the higher pro-
portion (0.9% vs 5.2% ) of undelivered letter of invita-
tion. Italian women born outside had a higher positiv-
ity to HPV (7.8% vs 6.1%) and a higher proportion of 
CIN3 (56.7% vs 44.7%) and of invasive cancers (17.2% 
vs 5.6%) in comparison with those born in Italy [28].
In Veneto Region, the detection rate for cervical 
intraepithelial neoplasia grade 2 or more (CIN2+) at 
first exam was higher for foreign women than for Ital-
ian ones (5.1 per 1000 for Italians vs 10.1 per 1000 for 
immigrants); it was slightly higher also at subsequent 
tests (2.2 per 1000 for Italians vs 3.1 per 1000 for im-
migrants) [29].
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Migration in Italy and cancer care
As regards the utilization of hospital services for can-
cer care in Italy, an evaluation of hospital discharge data 
collected by the Lazio Region (central Italy) for the 
year 2005 compared migrants and Italians [4]. In this 
study only people with a citizenship from less developed 
countries were considered immigrant and among them 
to have or not a regular stay permitted to split them into 
legal and illegal immigrants. The proportion of hospital 
discharges for neoplasms was lower among immigrants 
than Italians adults, presumably also for the younger 
mean age. In particular, in acute care the proportion 
of discharges for men was 5.2% of the total discharges 
among legal immigrant, 2.9% for illegal and 12.1% for 
Italians, and 7.1%, 3.0% and 10.8%, respectively for 
women. Almost the same result was confirmed for day 
care for which the proportions were: 8.9%, 7.0% and 
13.4% for men and 5.8%, 1.7% and 11.2% for women, 
respectively [4].
The standardized (European population) hospitaliza-
tion rates per 100 000 women for cervical cancer was 
higher among Immigrants than Italians (in 2008 it was 
23.5 vs 17.0 in northern Italy, 28.1 vs 15.6 in central Italy 
and 25.6 vs 11.6 in southern Italy). On the contrary the 
age-standardized hospitalization rate for mastectomy 
was lower for immigrant women than for Italians [9].
Within a cervical cancer screening program the pro-
portion of invasive surgery (hysterectomy or conisation) 
for cervical precancerous lesions (CIN3 and micro-
invasive ones) was as high among Italians (including 
migrant from Italy-like countries) as among foreigner 
women [20].
As regards cancer among children and adolescents 
(<  18 years), the proportion of hospitalizations was 
higher among legal immigrant 4.6% or illegal immi-
grant 4.1% that for Italians 2.3%, either for males (p < 
0.0001) and for females: 4.6%, 4.7% and 2.7%, respec-
tively (p < 0.0001) [6]. 
For children is relevant also the so called health-
migration, that is migration aimed at seeking a better 
medical care. In fact, the number of children with can-
cer coming from foreign countries is growing in special-
ized Italian centers. For example, the Gaslini Children’s 
Research Hospital documented an increasing number 
of immigrant patients from 2000 to 2008. This type of 
patients represents growing challenge which implies 
clinical, financial, administrative, logistical, psychologi-
cal difficulties [30]; moreover, there are the problems of 
communication with children and their families [31]. In 
this difficult process of communication foreign children 
replace the unknown word with drawings as a mean of 
self-expression, expressing their willingness to go back 
home [32].
As regards children and adolescents cured in one of 
the Italian Association of Pediatric hematology and 
Oncology centers (AIEOP) from 1999 to 2008, 4.1% 
(608) of them were born and living abroad and 3.7% 
(538) were born abroad and living in Italy. The num-
ber of foreign children patients has increased over time 
from 2.5% of the total case-series in 1999 to 8.1% in 
2009 [33]. The proportion of leukemia and lymphomas 
among immigrants, 59% (95% CI 56-62), was higher 
than among patients born in Italy, 48% (95% CI 47-49). 
Survival for acute lymphatic leukemia was lower for im-
migrants (10-year observed survival = 71.0%) than for 
Italians (80.7%) [33].
DISCUSSION
This review underlined the shortage of information 
on cancer incidence in immigrants in Italy, with only 
scattered and local studies available [2-7]. Therefore, 
the lack of a comprehensive picture addressing differ-
ent epidemiological measures and outcomes in a na-
tional scenario should be bridged.
In Italy, immigrants are becoming a growing compo-
nent of the population. Immigrants are sensibly young-
er than Italians and generally the migration selects the 
healthier among them as those more capable to stand 
the difficulties of migration. Therefore, cancer among 
immigrants is not overall a hot topic. However, since im-
migrants represent a melting pot of people they might 
hide specific needs for cancer prevention and care.
From this literature review we evidenced that im-
migrant is a rough definition. In fact, in the analyzed 
papers several different classifications have been used 
[34]: based on citizenship, on nationality (country of 
birth), on different grouping of countries (according to 
similarity to Italy, to the level of migration pressure or 
to the prevalence of HPV). Moreover, only some of the 
studies included also data and results for not legal im-
migrants, which presumably represent a not negligible 
and highly selected sample of people. Therefore, the 
first and unresolved problem in comparing results of 
studies on immigrants carried out in Italy is to find out 
if we are comparing the same people from one study to 
another one.
As regards cancers, immigrants, at least those coming 
from countries economically and culturally very differ-
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Figure 1 
Italy, 2015, age distribution of resident population by 
citizenship: Italian and foreign. From: www.demo.istat.it.
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ent from Italy, show a general lower incidence of cancer 
than Italian natives.
The reasons for this differences are complex because 
many factors could act simultaneously, including the 
different life expectation at birth, the role of competi-
tive causes of diseases and death, the possible different 
in intensity and typology exposure to carcinogens, up to 
the reliability of information related to the lower avail-
ability of cancer registration in such countries.
However, the role of infections cannot be minimized. 
In Italy, on average 8.5% of all the new cancers are due 
to infections [35]. Also among immigrants one of the 
main key targets is the HPV for its causative role in 
cervical cancer. Some of the countries from which the 
immigrants come have a high prevalence of HPV, more-
over, the immigrant population has a relevant propor-
tion of women and they are not aware about or used 
to undergo preventive tests. The variables that may en-
hance the risk for cervical cancer in the migrant female 
population are many and may depend on: a) social inte-
gration in the host-country: communication and racial 
difficulties, utilization of preventive care, discrimina-
tion, type of employment; b) personal-life: sexual be-
havior, number of partners, smoking and dietary habits, 
etc.; c) personal life conditions: homeless, refuge, legal 
status (irregular), temporary or permanent mobile sta-
tus, victim of prostitution with the possible major risk 
under such sexual conditions. 
Moreover, most of the immigrant women are not 
aware of cancer screening or facilities available, and the 
knowledge of cancer related problems is also very lim-
ited [36].
In Italy, cervical cancer is preventable either with 
vaccination of young girls and with regular screen-
ing of women 25-64 years old, both free of charge. 
Therefore, it is necessary to improve the knowledge 
of families on the benefits of HPV prevention of their 
daughters, and to support the participation of women 
to all public cancer screenings, especially cervical one. 
The target of prevention would decrease the requests 
addressed to hospitals, which for the most disadvan-
taged people may represent the reference for any ma-
jor health problem [34].
Among the many characteristics related to the care of 
immigrants we should consider also the barrier repre-
sented by different languages, as exemplified for child-
hood cancer patients but which should be considered 
also, for example, for a fully informed consent [37]. 
Moreover, cultural mediators and religious referees 
should be involved for achieving the best relationship 
with the patients and their families [30]. 
Screening is also invaluable for reducing the inequali-
ties [38], particularly important for the population of 
immigrants which has less economic resources for ac-
cessing the private health system. A lot of work is still 
necessary; in fact, although participation of immigrants 
to screening has increased over time the gap between 
Italians is still as wide as in the past [26]. 
We used information about screening tests from 
two sources: ONS and PASSI [23, 24], which comple-
mented each other. In fact, the different design of their 
surveys (observed data from organized programs vs self-
reported testing in a sample of the population) provides 
a comprehensive picture of the overall “coverage”. On 
the other hand, it may also justify discrepancies in the 
proportions of tested people (within and/or outside 
screening programme).
Some points belong directly to the organization of 
the screening programs, for example reducing the pro-
portion of undelivered letters increases the change for 
someone to have access to a service which otherwise 
would be unaffordable. 
CONCLUSIONS
Prevention is the most effective weapon against 
cancer. Italy offers freely cancer prevention to all the 
resident target population; immigrants should be in the 
bull’s eye. HPV vaccination and cervical cancer screen-
ing should be exploited in high risk migrant populations 
coping which those barriers which still hamper their 
comprehensive participation.
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